BioSpace News Archive

Deals

Summit Therapeutics to Host R&D Day 7 October 2019

Summit Therapeutics plc announces that it will host a research and development day for investors and media on 7 October 2019 from 8am-12pm EDT in New York City.

September 29, 2019
·
1 min read
Biotech Bay

GBT Announces Participation at the 2019 Cantor Global Healthcare Conference

Global Blood Therapeutics, Inc. announced that it will present at the 2019 Cantor Global Healthcare Conference in New York City on Wednesday, October 2, 2019, at 10:05 a.m. Eastern Time.

September 29, 2019
·
1 min read
Business

Catalyst Pharmaceuticals to Participate in the 2019 Cantor Global Healthcare Conference

Catalyst Pharmaceuticals, Inc. announced that it will participate in the 2019 Cantor Global Healthcare Conference in New York, NY.

September 29, 2019
·
2 min read
Policy

KnipBio Announces Latest Patent Approval from EU Patent Office

KnipBio announced that its patent titled Methylotrophs for Aquaculture and Animal Feed has been approved for grant by the European Patent Office.

September 29, 2019
·
2 min read
MedinCell announces that mdc-CWM progresses as planned

MedinCell’s CEO Christophe Douat states: “We are happy to report that the mdc-CWM program, partnered and in phase 2 clinical trial, is progressing well and on schedule.”

September 29, 2019
·
2 min read
Genetown

Resistance to immune checkpoint blocker drug linked to metabolic imbalance

Cancer cells appear to adapt to treatment with checkpoint blocker drugs by altering a metabolic process, leading to shorter survival for patients

September 29, 2019
·
4 min read
Eisai and Fronteo to Launch Coroban Tumbling and Falling Prediction System for Inpatients

Eisai Co., Ltd. and FRONTEO, Inc. announced that they have launched the tumbling and falling prediction system Coroban to medical institutions in Japan on September 26, 2019.

September 29, 2019
·
4 min read
Policy

Singapore Scientists Discover New Ways To Treat Liver Cancer

Studies on a novel protein that helps cancer cells to grow and spread may help in the development of more efficient therapies for liver cancer

September 29, 2019
·
4 min read
Deals

Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic

T3 Pharmaceuticals AG, a Basel-based company focusing on immuno-oncology, closes its second financing round of over 12M CHF with existing investors joined by Boehringer Ingelheim Venture Fund and Reference Capital SA.

September 29, 2019
·
5 min read
Helsinn announces abstract accepted for oral presentation at the EORTC Cutaneous Lymphoma Meeting 2019

Helsinn announces an abstract has been accepted for oral presentation at the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Meeting 2019 taking place from September 26-28, 2019 in Athens, Greece.

September 29, 2019
·
4 min read